A detailed history of Globeflex Capital L P transactions in Alkermes Plc. stock. As of the latest transaction made, Globeflex Capital L P holds 19,193 shares of ALKS stock, worth $569,072. This represents 0.05% of its overall portfolio holdings.

Number of Shares
19,193
Previous 19,193 -0.0%
Holding current value
$569,072
Previous $462,000 16.23%
% of portfolio
0.05%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$23.37 - $28.68 $28,674 - $35,190
1,227 Added 6.83%
19,193 $532,000
Q3 2023

Nov 13, 2023

BUY
$27.17 - $31.97 $218,338 - $256,910
8,036 Added 80.93%
17,966 $503,000
Q1 2023

May 12, 2023

BUY
$25.31 - $29.02 $116,729 - $133,840
4,612 Added 86.72%
9,930 $279,000
Q3 2022

Nov 14, 2022

BUY
$22.0 - $31.87 $113,740 - $164,767
5,170 Added 3493.24%
5,318 $119,000
Q2 2022

Aug 15, 2022

SELL
$26.4 - $30.54 $602,791 - $697,319
-22,833 Reduced 99.36%
148 $4,000
Q1 2022

May 13, 2022

SELL
$23.07 - $27.99 $606,856 - $736,276
-26,305 Reduced 53.37%
22,981 $605,000
Q4 2021

Feb 10, 2022

SELL
$21.47 - $32.08 $563,523 - $842,003
-26,247 Reduced 34.75%
49,286 $1.15 Million
Q3 2021

Nov 12, 2021

BUY
$23.37 - $32.13 $175,625 - $241,456
7,515 Added 11.05%
75,533 $2.33 Million
Q2 2021

Aug 12, 2021

BUY
$18.78 - $25.15 $1.28 Million - $1.71 Million
68,018 New
68,018 $1.67 Million
Q2 2020

Aug 12, 2020

SELL
$13.31 - $19.41 $87,832 - $128,086
-6,599 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$13.06 - $21.24 $33,067 - $53,779
2,532 Added 62.26%
6,599 $95,000
Q1 2019

May 10, 2019

BUY
$28.4 - $36.49 $115,502 - $148,404
4,067 New
4,067 $148,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.87B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.